CoChat

OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects

Open access
Moreno-Navarrete, José María, Ortega, Francisco J., Rodríguez-Hermosa, José-Ignacio, Sabater, Mònica, Pardo, Gerard, Ricart, Wifredo, Fernández-Real, José Manuel · 2011 · Diabetes

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Metformin has been well characterized in vitro as a substrate of liver-expressed organic cation transporters (OCTs). We investigated the gene expression and protein levels of OCT-1 and OCT-2 in adipose tissue and during adipogenesis and evaluated their possible role in metformin action on adipocytes. RESEARCH DESIGN AND METHODS: OCT1 and OCT2 gene expressions were analyzed in 118 adipose tissue samples (57 visceral and 61 subcutaneous depots) and during human preadipocyte differentiation. To test the possible role of OCT1 mediating the response of adipocytes to metformin, cotreatments with cimetidine (OCT blocker, 0.5 and 5 mmol/l) and metformin were made on human preadipocytes and subcutaneous adipose tissue (SAT). RESULTS: OCT1 gene was expressed in both subcutaneous and visceral adipose tissue. In both fat depots, OCT1 gene expression and protein levels were significantly increased in obese subjects. OCT1 gene expression in isolated preadipocytes significantly increased during differentiation in parallel to adipogenic genes. Metformin (5 mmol/l) decreased the expression of lipogenic genes and lipid droplets accumulation while increasing AMP-activated protein kinase (AMPK) activation, preventing differentiation of human preadipocytes. Cotreatment with cimetidine restored adipogenesis. Furthermore, metformin decreased IL-6 and MCP-1 gene expression in comparison with differentiated adipocytes. Metformin (0.1 and 1 mmol/l) decreased adipogenic and inflammatory genes in SAT. OCT2 gene expression was not detected in adipose tissue and was very small in isolated preadipocytes, disappearing during adipogenesis. CONCLUSIONS: OCT1 gene expression and protein levels are detectable in adipose tissue. Increased OCT1 gene expression in adipose tissue of obese subjects might contribute to increased metformin action in these subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db10-0805

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. OCT1, FASN, ACC1, PPARγ and adiponectin gene expression during differentiation of human preadipocytes from obese (A) and lean subjects (B). *P < 0.05 vs. day 0.
FIG. 1. OCT1, FASN, ACC1, PPARγ and adiponectin gene expression during differentiation of human preadipocytes from obese (A) and lean subjects (B). *P < 0.05 vs. day 0.CC BY-NC-ND · PubMed Central
FIG. 2. OCT1 and FASN protein levels in differentiated and nondifferentiated preadipocytes at day 14. *P < 0.05 vs. nondifferentiated preadipocytes.
FIG. 2. OCT1 and FASN protein levels in differentiated and nondifferentiated preadipocytes at day 14. *P < 0.05 vs. nondifferentiated preadipocytes.CC BY-NC-ND · PubMed Central
FIG. 3. FASN, ACC1, PPARγ, adiponectin, OCT1, FABP4, IL-6, MCP-1 gene expressions after metformin (5 mmol/l) and cimetidine (0.5 and 5 mmol/l) cotreatments in differentiated human adipocytes. *P < 0.05 vs. differentiated adipocytes; +P < 0.05 vs. metformin (5 mmol/l) treatment.
FIG. 3. FASN, ACC1, PPARγ, adiponectin, OCT1, FABP4, IL-6, MCP-1 gene expressions after metformin (5 mmol/l) and cimetidine (0.5 and 5 mmol/l) cotreatments in differentiated human adipocytes. *P < 0.05 vs. differentiated adipocytes; +P < 0.05 vs. metformin (5 mmol/l) treatment.CC BY-NC-ND · PubMed Central
FIG. 4. Oil red O staining and LDH activity in differentiated human adipocytes, and after metformin (5 mmol/l) and cimetidine (0.5 and 5 mmol/l) cotreatment. *P < 0.05 vs. differentiated adipocytes; +P < 0.05 vs. metformin (5 mmol/l) treatment. (A high-quality color representation of this figure is available in the online issue.)
FIG. 4. Oil red O staining and LDH activity in differentiated human adipocytes, and after metformin (5 mmol/l) and cimetidine (0.5 and 5 mmol/l) cotreatment. *P < 0.05 vs. differentiated adipocytes; +P < 0.05 vs. metformin (5 mmol/l) treatment. (A high-quality color representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 5. Effects of metformin (5 mmol/l) and cimetidine (0.5 and 5 mmol/l) cotreatment on p172ThrAMPK, p79SerACC1, and ACC1 concentrations. *P < 0.05 vs. differentiated adipocytes; +P < 0.05 vs. metformin (5 mmol/l) treatment.
FIG. 5. Effects of metformin (5 mmol/l) and cimetidine (0.5 and 5 mmol/l) cotreatment on p172ThrAMPK, p79SerACC1, and ACC1 concentrations. *P < 0.05 vs. differentiated adipocytes; +P < 0.05 vs. metformin (5 mmol/l) treatment.CC BY-NC-ND · PubMed Central
FIG. 6. FASN, ACC1, PPARγ, adiponectin, OCT1, IL-6, MCP-1 gene expressions after metformin (0.1 and 1 mmol/l) in subcutaneous adipose tissue explants. *P < 0.05 vs. control (vehicle) treatment.
FIG. 6. FASN, ACC1, PPARγ, adiponectin, OCT1, IL-6, MCP-1 gene expressions after metformin (0.1 and 1 mmol/l) in subcutaneous adipose tissue explants. *P < 0.05 vs. control (vehicle) treatment.CC BY-NC-ND · PubMed Central
FIG. 7. OCT1 relative gene expression in both visceral and subcutaneous adipose tissue according to obesity status.
FIG. 7. OCT1 relative gene expression in both visceral and subcutaneous adipose tissue according to obesity status.CC BY-NC-ND · PubMed Central
FIG. 8. A: OCT1 protein levels in subcutaneous adipose tissue according to obesity status. Non-normalized OCT1 protein and normalized for β-Actin values (relative levels) are shown. B: OCT1 gene expression in stromovascular cells and mature adipocytes from subcutaneous adipose tissue.
FIG. 8. A: OCT1 protein levels in subcutaneous adipose tissue according to obesity status. Non-normalized OCT1 protein and normalized for β-Actin values (relative levels) are shown. B: OCT1 gene expression in stromovascular cells and mature adipocytes from subcutaneous adipose tissue.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 23 references

Cited by

See all 100

Metadata

Authors
Moreno-Navarrete, J. M., Ortega, F. J., Rodríguez-Hermosa, J.-I., Sabater, M., Pardo, G., Ricart, W., & Fernández-Real, J. M.
Affiliations
  • From the Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomédica de Girona, CIBER Fisiopatología de la Obesidad y Nutrición CB06/03/010, Girona. Spain.
  • Institut d'Investigació Biomèdica de Girona (ES)
Venue
Diabetes
Published
2010-10-18
Volume
60
Issue
1
Pages
168-176
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2137586574
Cited by
100
References
22
Citations by year
2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 9 · 2018: 12 · 2017: 3 · 2016: 9 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 5
FWCI
3.12
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
OCT1, organic cation transporters, metformin, adipocytes, adipose tissue, obesity, adipogenesis, preadipocyte differentiation, cimetidine, AMPK, lipogenesis, visceral adipose tissue, subcutaneous adipose tissue, interleukin-6, MCP-1, inflammation, drug transport
MeSH terms
Organic Cation Transporter 2, Acetyl-CoA Carboxylase, Acetyltransferases, Adenylate Kinase, Azo Compounds, Cell Differentiation, Coloring Agents, Gene Expression Regulation, Humans, Hypoglycemic Agents, Metformin, Obesity, RNA, Gastric Bypass, Gene Expression, Adipocytes, Organic Cation Transport Proteins, Organic Cation Transporter 1, PPAR gamma, Fatty Acid Synthase, Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects. https://app.cochat.ai/papers/10.2337/db10-0805
The paper
Moreno-Navarrete, J. M., Ortega, F. J., Rodríguez-Hermosa, J.-I., Sabater, M., Pardo, G., Ricart, W., & Fernández-Real, J. M. (2011). OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects. Diabetes. https://doi.org/10.2337/db10-0805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.